The federal health‑care landscape is about to see a new breed of artificial intelligence in action. Basys.ai, a specialist in domain‑specific AI for health‑care operations, announced a collaboration with ePathUSA, the prime contractor for the Centers for Medicare & Medicaid Services (CMS) Artificial Intelligence Medical Record Review (AI MRR) pilot. The partnership, disclosed on March 23 2026, aims to augment the traditionally labor‑intensive process of medical‑record review with an “agentic AI” infrastructure that can interpret complex clinical documentation while preserving auditability and regulatory compliance.
A targeted AI boost for program integrity
Medical‑record review is the linchpin of program integrity across Medicare, Medicaid and other federal health initiatives. Detecting fraud, waste, and abuse (FWA) typically requires teams of human reviewers to sift through dense clinical notes, billing codes and policy language—a process that is both time‑consuming and prone to inconsistency. The Basys.ai–ePathUSA effort seeks to inject an AI layer that can surface relevant clinical facts, apply policy logic, and generate explanations that regulators can scrutinize.
“Applying agentic AI to one of the most intricate operational challenges in health‑care is a significant step forward,” said Amber Nigam, CEO of Basys.ai. “Program integrity demands tools that can parse nuanced medical documentation while staying transparent and aligned with the regulatory framework. Our expertise in utilization management and FWA positions us to build AI that works reliably in real‑world health settings.”
How the technology is positioned
Basys.ai’s platform is built around “agentic” AI—systems that not only generate outputs but also reason about policy constraints and can be queried for justification. In this pilot, the AI will:
- Interpret policy language to determine eligibility and compliance criteria.
- Analyze medical records for clinical indicators tied to potential FWA.
- Produce auditable decision trails that human reviewers can validate.
ePathUSA’s role as the prime contractor for the CMS AI MRR pilot adds operational depth. “Our focus is on marrying deep domain expertise with cutting‑edge AI to advance CMS’s mission of safeguarding program integrity,” explained Hari Nallure, President of ePathUSA. “Partnering with Basys.ai lets us evaluate how AI can boost both efficiency and accuracy in record review.”
Industry context: AI in regulated health care
The move reflects a broader industry shift toward specialized AI solutions for regulated sectors. While large language models dominate headlines, health‑care regulators have been wary of “black‑box” systems that lack explainability. Basys.ai’s emphasis on transparent reasoning aligns with emerging compliance expectations, such as the FDA’s proposed framework for AI‑enabled medical devices that stresses traceability and human oversight.
“Medical‑record review has historically been a manual, time‑intensive process,” noted Arpan Saxena, CIO of Basys.ai. “Domain‑specific AI models, coupled with structured reasoning, can accelerate fact‑finding while retaining the level of transparency required in regulated environments.”
Recognition that underscores credibility
The partnership is bolstered by a series of accolades that signal Basys.ai’s growing credibility in the health‑tech arena:
- Top 10 finalist in CMS’s “Crushing Fraud, Waste, and Abuse” Chili Cook‑Off competition, selected from over 250 submissions.
- Featured in Gartner’s Healthcare AI landscape, highlighting its role in advancing AI‑driven health‑care operations.
- Publication of its perspective on generative AI in Harvard Business Review, discussing the trade‑offs between generalist and specialized models for utilization management.
- Appearances on TEDx and the Harvard Chan Studio, where the company’s leadership has discussed incentive alignment and data‑driven health‑care delivery.
- Inclusion in Rock Health’s Top 50 in Digital Health and recognition by the Boston Business Journal’s 2025 list.
- Coverage in STAT News, emphasizing the importance of reliable AI in regulated health settings.
These endorsements suggest that Basys.ai’s approach resonates with both technology analysts and health‑care policymakers.
Enterprise implications
For enterprises that develop or integrate AI in regulated domains, the Basys.ai–ePathUSA collaboration offers several takeaways:
- Specialized versus generic models – The pilot underscores the advantage of domain‑specific AI that can be audited against policy rules, a contrast to the “one‑size‑fits‑all” approach of many large language models.
- Explainability as a product feature – By delivering decision trails, the solution meets a critical compliance checkpoint that many enterprise AI deployments overlook.
- Scalable augmentation of human labor – The AI layer promises to reduce the time clinicians and auditors spend on record triage, freeing resources for higher‑value tasks.
- Strategic partnerships – Aligning with a prime contractor like ePathUSA provides a pathway to government pilots, an attractive route for AI vendors seeking early‑stage validation.
digital health initiatives benefit from such collaborations, highlighting the cross‑industry relevance of advanced automation.
Looking ahead
The CMS AI MRR pilot is slated to run through the next fiscal year, with performance metrics to be disclosed upon completion. Success could pave the way for broader adoption of agentic AI across other CMS programs, such as prior authorization and claims adjudication, where policy complexity and auditability are equally critical.
Basys.ai’s leadership remains focused on expanding its agentic AI suite to cover additional health‑care workflows, emphasizing a roadmap that balances innovation with the stringent transparency demands of public health programs.
“Healthcare is entering a phase where AI will increasingly support complex operational decisions,” Nigam added. “Our objective is to build agentic AI systems that health‑care institutions and regulators can trust—systems that improve efficiency while maintaining the transparency and accountability required in public health programs.”
program integrity remains at the core of these efforts, ensuring that financial stewardship aligns with patient care outcomes.
enterprise implications of this pilot will be closely monitored by both the private sector and governmental agencies.
Power Tomorrow’s Intelligence — Build It with TechEdgeAI
